Arbutus Biopharma Corpora... (ABUS)

ABUS trades at $4.41, 47.0% above the near-term max pain of $3 expiring Oct 17, 2025 (18 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($1-$5), signaling increased put positioning or downside protection. Key magnetic zone at 4 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ABUS shows a downward trend from 5 to 1, indicating bearish sentiment or hedging activity. The 117% spread signals divergent expectations across timeframes. Most levels below 4.41 may cap rallies. Strong magnetic level at 4 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.